Forward and reverse translational approaches to predict efficacy of neutralizing respiratory syncytial virus (RSV) antibody prophylaxis.

EBioMedicine · 2021 · PMC8603022 · PMID 34775220

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Analysis of the quantitative culture data demonstrated a clear trend of mean VL-AUC reduction in a dose-dependent manner across the dose range of 100 to 900 mg of MK-1654 ( Fig. 4 d).

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.